North Growth Management’s Zymeworks ZYME Stock Holding History

North Growth Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2M	Hold	46,000	–	–	0.15%	46
2026 Q1	$1.14M	Buy	46,000 +1,000	+2%	+$23.7K	0.17%	46
2025 Q4	$1.18M	Sell	45,000 -37,000	-45%	-$807K	0.19%	46
2025 Q3	$1.41M	Sell	82,000 -15,000	-15%	-$215K	0.25%	46
2025 Q2	$1.22M	Hold	97,000	–	–	0.23%	46
2025 Q1	$1.15M	Hold	97,000	–	–	0.24%	46
2024 Q4	$1.42M	Hold	97,000	–	–	0.27%	45
2024 Q3	$1.22M	Hold	97,000	–	–	0.23%	46
2024 Q2	$825K	Hold	97,000	–	–	0.16%	44
2024 Q1	$1.02M	Hold	97,000	–	–	0.19%	45
2023 Q4	$1.01M	Hold	97,000	–	–	0.21%	46
2023 Q3	$614K	Sell	97,000 -23,000	-19%	-$170K	0.14%	48
2023 Q2	$1.04M	Hold	120,000	–	–	0.21%	47
2023 Q1	$1.09M	Buy	120,000 +45,000	+60%	+$392K	0.23%	44
2022 Q4	$591K	Hold	75,000	–	–	0.13%	44
2022 Q3	$462K	Hold	75,000	–	–	0.12%	45
2022 Q2	$399K	Buy	+75,000	New	+$454K	0.09%	46
2022 Q1	–	Sell	-69,000	Closed	-$1.14M	–	56
2021 Q4	$1.14M	Buy	69,000 +6,000	+10%	+$125K	0.19%	48
2021 Q3	$1.83M	Buy	63,000 +5,000	+9%	+$166K	0.32%	48
2021 Q2	$2.02M	Hold	58,000	–	–	0.33%	49
2021 Q1	$1.83M	Buy	58,000 +9,000	+18%	+$366K	0.33%	49
2020 Q4	$2.33M	Hold	49,000	–	–	0.48%	46
2020 Q3	$2.29M	Hold	49,000	–	–	0.5%	46
2020 Q2	$1.77M	Hold	49,000	–	–	0.43%	47
2020 Q1	$1.75M	Hold	49,000	–	–	0.49%	46
2019 Q4	$2.24M	Hold	49,000	–	–	0.5%	43
2019 Q3	$1.22M	Buy	+49,000	New	+$1.23M	0.29%	45

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

North Growth Management's ZYME Position: Q2 2026 in Review

North Growth Management held its Zymeworks (ZYME) position steady in Q2 2026 at 46,000 shares worth $1.2M. The position accounts for 0.15% of the portfolio, ranked #46.

North Growth Management first reported a position in ZYME in Q3 2019 and has held it in 27 quarters since. The position peaked at $2.33M in Q4 2020. 203 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

North Growth Management held 46,000 shares of Zymeworks worth $1.2M as of Q2 2026.
North Growth Management left its Zymeworks share count unchanged in Q2 2026.
Zymeworks made up 0.15% of North Growth Management's portfolio in Q2 2026, its #46 holding.
North Growth Management first reported a position in Zymeworks in Q3 2019 and has held it in 27 quarters since.
North Growth Management's Zymeworks position peaked at $2.33M in Q4 2020.
203 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on North Growth Management's 13F filing for Q2 2026, filed 22 Jul 2026.